| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2013 | A Phase I/IIa study of safety, tolerability, and pharma-cokinetic profiles of TG-2349, a pan-genotypic HCV protease inhibitor, in healthy East Asian and Caucasian subjects, and its antiviral activity in chronic hepatitis C patients | Tsai, Chen-En; Chang, Li-Wen; Chang, Yu-Ting; Hsu, Chiung-Yuan; Chen, Chih-Ming; Tsai, Cheng-Yuan; Lin, Chu-Chung; King, Chi-Hsin R.; Liu, Chun-Jen; Chen, Ding-Shinn; Hsu, Ming-Chu | Hepatology | | | |
| 2014 | A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants | Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
| 2014 | A ten-year follow-up of patients with dual chronic hepatitis B and C virus infections: Outcomes and determinants | Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
| 2013 | Adverse Events of Ribavirin Plus Pegylated Interferon Combination Therapy for Hepatitis C Patients in Taiwan: A Population-Based Study | Chu, Yu-Tseng; Liu, Chun-Jen; Shau, Wen-Yi; Wu, Chi-Shin; Dong, Yaa-Hui; Kuo, Raymond N. C.; Lai, Chiu-Ling; Chen, Pei-Jer; Lai, Mei-Shu | Pharmacoepidemiol. Drug Saf. | | | |
| 2013 | Adverse Events of Ribavirin Plus Pegylated Interferon Combination Therapy for Hepatitis C Patients in Taiwan: A Population-Based Study | Chu, Yu-Tseng; Liu, Chun-Jen; 郭年真 | Pharmacoepidemiol. Drug Saf. | | | |
| 2009 | Analysis of Hbsag Levels in Patients Coinfected with Hepatitis B Virus and Hepatitis C Virus Treated with Peginterferon Alfa-2a and Ribavirin | CHEN, CHIEN-JEN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN; WU, SHUN-SHENG; LIAO, LI-YING; CHEN, CHI-LING; KAO, JIA-HORNG; LIU, CHUN-JEN; JENG, YUNG-MING; CHEN, PEI-JER; CHEN, DING-SHINN | JOURNAL OF HEPATOLOGY | | | |
| 2012 | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update (vol 6, pg 531, 2012) | Liaw, Yun-Fan; Kao, Jia-Horng; Piratvisuth, Teerha; Chan, Henry Lik Yuen; Chien, Rong-Nan; Liu, Chun-Jen; Gane, Ed; Locarnini, Stephen; Lim, Seng-Gee; Han, Kwang-Hyub; Amarapurkar, Deepak; Cooksley, Graham; Jafri, Wasim; Mohamed, Rosmawati; Hou, Jin-Lin; Chuang, Wan-Long; Lesmana, Laurentius A.; Sollano, Jose D.; Suh, Dong-Jin; Omata, Masao | Hepatol. Int. | | |  |
| 2013 | Comparative Effectiveness of Interferon and Pegylated Interferon against Chronic Hepatitis B in Taiwan | Liu, Chun-Jen; Yeh, Yi-Chun; Kau, Raymond N. C.; Lai, Chiu-Ling; Yang, Yen-Yun; Lai, Mei-Shu; Chen, Pei-Jer | Pharmacoepidemiol. Drug Saf. | | | |
| 2013 | Comparative Effectiveness of Interferon and Pegylated Interferon against Chronic Hepatitis B in Taiwan | Liu, Chun-Jen; Yeh, Yi-Chun; Kau, Raymond N. C.; Lai, Chiu-Ling; Lai, Chiu-Ling; Yang, Yen-Yun; Yang, Yen-Yun; Lai, Mei-Shu; Lai, Mei-Shu; Chen, Pei-Jer | Pharmacoepidemiol. Drug Saf. | | | |
| 2013 | Comparative Effectiveness of Lamivudine and Interferon or Pegylated Interferon Against Chronic Hepatitis B in Taiwan | Yeh, Yi-Chun; Liu, Chun-Jen; Lai, Chiu-Ling; Kuo, Raymond N. C.; Chen, Ho-Min; Chen, Pei-Jer; Lai, Mei-Shu | Pharmacoepidemiol. Drug Saf. | | | |
| 2013 | Comparative Effectiveness of Lamivudine and Interferon or Pegylated Interferon Against Chronic Hepatitis B in Taiwan | Yeh, Yi-Chun; Yeh, Yi-Chun; Liu, Chun-Jen; Liu, Chun-Jen; Lai, Chiu-Ling; Kuo, Raymond N. C.; Chen, Ho-Min; Chen, Pei-Jer; Lai, Mei-Shu | Pharmacoepidemiol. Drug Saf. | | | |
| 2015 | Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy | Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
| 2015 | Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy | Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng | J. Gastroenterol. Hepatol. | | | |
| 2012 | Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy | Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
| 2009 | Hbsag Clearance Continues to Increase Post-Treatment in Patients with Hcv Hbv Coinfection Treated with Peginterferon Alfa-2a Plus Ribavirin: 1.5 Year Follow-Up | LIU, CHUN-JEN; WU, SHUN-SHENG; CHAO, YOU- CHEN; YANG, SIEN-SING; LIN, CHIH-LIN; KAO, JIA-HORNG; LIU, CHEN-HUA; CHEN, PEI-JER; CHEN, DING-SHINN; CHUANG, WAN-LONG; LEE, CHUAN-MO; YU, MING-LUNG; LU, SHENG-NAN | HEPATOLOGY | | | |
| 2012 | HBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patients | Su, Tung-Hung; Liu, Chun-Jen; Yang, Hung-Chih; Cheng, Huei-Ru; Jeng, Yung-Ming; Liu, Chen-Hua; Tseng, Tai-Chung; Chen, Chi-Ling; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng | Hepatology | | | |
| 2022 | Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase | Tseng, Tai-Chung; Hosaka, Tetsuya; Liu, Chun-Jen; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; Yang, Hung-Chih; CHEN-HUA LIU ; PEI-JER CHEN ; Chen, Hsiu-Hsi; JIA-HORNG KAO | The American journal of gastroenterology | 1 | 0 | |
| 2008 | Hepatitis B Virus Basal Core Promoter Mutation and DNA Load Correlate with Expression of Hepatitis B Core Antigen | LIU, CHUN-JEN; CHEN, PEI-JER; JENG, YUNG- MING; KAO, JIA-HORNG; CHEN, DING-SHINN | HEPATOLOGY | | | |
| 2022 | Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study | CHEN-HUA LIU ; HSIN-YUN SUN ; Peng, Cheng-Yuan; SZU-MIN HSIEH ; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; Liu, Chun-Jen; Sheng, Wang-Hui; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; TUNG-HUNG SU ; Tseng, Tai-Chung; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Open forum infectious diseases | 0 | 0 | |
| 2008 | A Higher Alanine Aminotransferase Level Correlates with Earlier Hepatitis B E Antigen Seroconversion in Lamivudine-Treated Chronic Hepatitis B Patients | TSENG, TAI-CHUNG; LIU, CHUN-JEN; WANG, CHIA-CHI; CHEN, PEI-JER; LAI, MING-YANG; KAO, JIA-HORNG; CHEN, DING-SHINN; KAO, JIA- HORNG | LIVER INTERATIONAL | | | |
